Piramal Pharma inducts three new board members

07 July 2022 | News

Peter Stevenson, Nathalie Leitch and Sridhar Gorthi have been added to the board of directors

Piramal Pharma announced the addition of Peter Stevenson, Nathalie Leitch and Sridhar Gorthi to the board of directors. These new appointments, which come ahead of the planned de-merger of PPL from Piramal Enterprises (PEL), will assist in maintaining high governance for the new listed corporate entity.  

 

The appointments will add to the well-diversified experience that currently exists on the PPL board. Led by Chairperson Nandini Piramal and Piramal Global Pharma CEO Peter DeYoung, the Piramal Pharma board also includes leaders such as S Ramadorai, Neeraj Bhardwaj, Jairaj Purandare and Vivek Valsaraj. 

 

Stevenson brings in-depth knowledge in contract manufacturing, business operations, supply chain management and operating in a complex regulatory environment. Gorthi is an authority in corporate law, M&A and private equity. His experience spans manufacturing, pharmaceuticals, insurance, banking and financial services, technology, telecom and media. Leitch is a subject matter expert in pharmaceuticals and the US generics industry, with domain experience in creative product strategies and formulations.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account